Disclosure hits industry

 In Australia, NewZealand, Pharmacy
THE Australian pharmaceutical industry continues to face significant headwinds, with a new report from consulting firm PricewaterhouseCoopers revealing the ongoing impact of PBS reforms and price disclosure.


Conducted in conjunction with Medicines Australia, the Issues and Decisions report is the outcome of a confidential survey of a wide cross- section of industry participants. Pharmacy Daily – Read More.

Recent Posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.